ENDPOINTS

HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts down

A Boston biotech trying to bring transfer RNA (tRNA) biology to the drug development field has shuttered operations, Endpoints News has learned. The startup, called hC Bioscience, broke onto the scene in 2022 hoping to ...

Mar 17, 2025 - 12:09
 0
HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts down
A Boston biotech trying to bring transfer RNA (tRNA) biology to the drug development field has shuttered operations, Endpoints News has learned. The startup, called hC Bioscience, broke onto the scene in 2022 hoping to ...
Read More

Tags:

Previous Article

Avidity heads to FDA with exon 44 skipping Duchenne muscular dystrophy drug

Next Article

How insurers can protect and nurture innovative low-carbon energy projects

Related Posts

Novo's weight loss drug helps curb some drinking habits, small study shows

Novo's weight loss drug helps curb some drinking habits...

Feb 12, 2025  0

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai a...

Feb 28, 2025  0

Biohaven gets FDA priority review for neuro disease drug after refuse-to-file

Biohaven gets FDA priority review for neuro disease dru...

Feb 11, 2025  0